Watch Ticker

Kodiak Sciences Inc Common Stock

Go to Kodiak Sciences Inc Common Stock Website

$7.83

0.52 (7.11%)

Live

Previous Close

$7.31

Day Range

$7.19 - $7.8291

Previous Day Range

$6.42 - $7.35

Market Cap

$350.9 million USD

Day Vol.

225997

Previous Day Vol.

301281

Currency

USD

Primary Exchange

Nasdaq

Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is BLA, which is a novel antibody biopolymer conjugate, in treatment-naive subjects ...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Researchandmarkets.Com - Diabetic Retinopathy Global Clinical Trials Review 2024: Region, country (G7 & E7), phase, trial status, End-points Status and Sponsor Type

The report provides an overview of the global clinical trials landscape for diabetic retinopathy, including details on trial numbers, enrollment, and status across different regions, countries, phases, and sponsor types. It also highlights prominent drugs and companies involved in these trials.

Related tickers: NVS, REGN, ABBV, PFE, ALC, KOD.

Read Full Article

Zacks Equity Research - Should You Hold Kodiak Sciences (KOD) Stock in Your Portfolio?

Kodiak Sciences (KOD) is evaluating its lead candidate, tarcocimab, in a late-stage study for diabetic retinopathy, which is expected to support a regulatory filing for three eye disease indications.

Related tickers: CGEN, KOD, ANVS, ALXO.

Read Full Article

Trending Tickers

Please sign in to view